Diagnostic value and reproducibility of fine-needle aspiration cytology in canine malignant lymphoma

Veterinary Quarterly

Volumn 18, Issue 3, 1996, Pages 112-115

  Teske, E ^a   van Heerde, P ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CLASSIFICATION; DOG; DOG DISEASE; FEMALE; IMMUNOPHENOTYPING; LYMPH NODE; LYMPHOMA; MALE; NEEDLE BIOPSY; NONHODGKIN LYMPHOMA; OBSERVER VARIATION; PATHOLOGY; REPRODUCIBILITY; STANDARD;

ANIMALS; BIOPSY, NEEDLE; DOG DISEASES; DOGS; FEMALE; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 0030226153     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.1996.9694630     Document Type: Article

References (28)

1. Carter RF, Valli VEO, and Lumsden JH. The cytology, histology, and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation. Can J Vet Res 1986; 50:154–64.
2. Carter RF, Harris CK, Withrow SJ, Valli VEO, and Susaneck SI Chemotherapy of canine lymphoma with histopathological correlation: doxorubicin alone compared to COP as first treatment regimen. J Am Anim Hosp Assoc 1987; 23: 587–96.
3. Carter RF, and Valli VEO. Advances in the cytologic diagnosis of canine lymphoma. Sem Vet Med Surg (Small animals) 1988; 3: 167–75.
4. Carter TR, Feldman PS, Innes DJ, Frierson HF, and Frigy AF. The role of fine-needle aspiration cytology in the diagnosis of lymphoma. Acta Cytologica 1988; 32: 848–53.
5. Ferrer L, Foudevilla D, Rabanal R, and Rannis A. Detection of T lymphocytes in canine tissue embedded in paraffin wax by means of antibody to CD3 antigen. J Comp Pathol 1992; 106: 311–4.
6. Fleiss JL. Statistical methods for rates and proportions. 2nd edition. J. Wiley & Sons, New York, 1981: 212–36.
7. Greenlee PG, Filippa DA, Quimby FW, Patnaik AK, Calvano SE, Matus RE, Kimmel M, Hurvitz AI, and Lieberman PH. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 1990; 66: 480–90.
8. Hastup N, Hamilton-Dutoit S, Ralfkiaer E, and Pallesen G. Peripheral Tcell lymphomas: an evaluation of reproducibility of the updated Kiel classification. Histopathology 1991; 18: 99–105.
9. Landis RJ, and Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–74.
10. Lennert K. Handbuch des Speziellen Pathologischen Anatomic und Histologie. Springer Verlag, Berlin, 1978.
11. Lennert K, and Feller AC. Histopathologie der Non-Hodgkin-Lymphome (nach der aktualisierten Kiel-Klassifikation). 2nd Edition. Berlin, Springer Verlag 1990.
12. MacEwen EG, Hayes AA, Matus RE, and Kurzman I. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog. 147 cases (1978-1981). J Am Vet Med Assoc 1987; 190: 564–8.
13. MacEwen EG, Rosenthal RC, Fox LE, Loar AS, and Kurzman ID. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double blind study in canine lymphoma. J Vet Int Med 1992; 6: 230–4.
14. McKenzie JL, and Fabre JW. Studies with a monoclonal antibody on the distribution of Thy-1 in the lymphoid and extracellular connective tissues of the dog. Transplantation 1981; 31: 275–82.
15. Mills JN. Lymph node cytology. Vet Clin North Am 1989; 19: 697–717.
16. Moore PF, Rossitto PV, and Danilenko DM. Canine leukocyte integrins: characterization of a CD18 homologue. Tissue Antigens 1990; 36: 211–20.
17. Moore PF, Rossitto PV, Danilenko DM, Wielenga JJ, Raff RF, and Severns E. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens 1992; 40: 75–85.
18. National Cancer Institute. The non-Hodgkin’s lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–35.
19. Rosenthal RC, and MacEwen EG. Treatment of lymphoma in dogs. J Am Vet Med Assoc 1990; 196: 774–81.
20. Skoog L, and Tani E. The role of fine-needle aspiration cytology in the diagnosis of non-Hodgkin’s lymphoma. Diagn Oncol 1991; 1: 12–8.
21. Spieler P, and Schmid U. How exact are the diagnosis and classification of malignant lymphomas from aspiration biopsy smears? Path Res Pract 1978; 163: 232–50.
22. SPSS for Windows, Base System User’s Guide Release 5.0, SPSS Inc. Chicago, 1992: 201–3.
23. Squire RA, Bush M, Melby EC, Neeley LM, and Yarbrough B. Clinical and pathologic study of canine lymphoma: clinical staging, cell classification, and therapy. J Natl Cancer Inst 1973; 51: 565–74.
24. Teske E, Rutteman GR, Heerde P van, and Misdorp W. Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin’s lymphoma. Eur J Cancer 1990; 26: 891–95.
25. Teske E, Wisman P, Moore PF, and Heerde P van. Histological classification and immunetyping of canine malignant lymphomas. Unexpected high frequency of T-cell lymphomas with B-cell morphology. Exp Hematol 1994; 22: 1179–87.
26. Teske E, Ileerde P van, Rutteman GR, Kurzman ID, Moore PF, and MacEwen EG. Prognostic factors for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc 1994; 205: 1722–8.
27. Heerde P van, Go DMDS, Koolman-Schellekens MA, and Peterse JL. Cytodiagnosis of non-Hodgkin’s lymphoma. Virchows Arch (Pathol Anat) 1984; 403: 213–33.
28. Zinkl JG, and Keeton KS. Lymph node cytology. III Neoplasia. Californian Veterinarian 1981; 5: 20–3.